Results 221 to 230 of about 410,667 (361)

Test–retest variability of mesopic microperimetry‐associated parameters in patients with retinitis pigmentosa: REPEAT Study Report No. 2

Acta Ophthalmologica, Volume 103, Issue 3, Page 313-326, May 2025.
Abstract Purpose Understanding test–retest variability (TRV) of mesopic microperimetry is critical for defining meaningful treatment effects in retinitis pigmentosa (RP) trials. This study uniquely evaluates intra‐ and intervisit TRV and coefficients of repeatability (CoRs) for microperimetry parameters in RP patients with varying best‐corrected visual
Jessica S. Karuntu, Maximilian Pfau, Jasleen K. Jolly, Camiel J. F. Boon   +3 more
wiley   +1 more source

Laser Photocoagulation Combined with Intravitreal Triamcinolone Acetonide Injection in Proliferative Diabetic Retinopathy with Macular Edema [PDF]

, 2007
Kyung Seek Choi, Jin Kwon Chung, Sang Hyun Lim   +2 more
openalex   +1 more source

Natural products targeting tumour angiogenesis

British Journal of Pharmacology, Volume 182, Issue 10, Page 2094-2136, May 2025.
Abstract Tumour angiogenesis is the formation of new blood vessels to support the growth of a tumour. This process is critical for tumour progression and metastasis, making it an attractive approach to cancer therapy. Natural products derived from plants, animals or microorganisms exert anti‐angiogenic properties and can be used to inhibit tumour ...
Xiaohua Lu, Lara Johanna Friedrich, Thomas Efferth   +2 more
wiley   +1 more source

Ranibizumab with luseogliflozin in type 2 diabetes with diabetic macular oedema: A randomised clinical trial

Diabetes, Obesity and Metabolism, Volume 27, Issue 5, Page 2473-2484, May 2025.
Abstract Aims Anti‐vascular endothelial growth factor (VEGF) therapy is the standard treatment for diabetic macular oedema (DMO); however, unmet needs remain. This study aimed to assess the effectiveness of sodium‐glucose cotransporter 2 inhibitors (SGLT2i) in treating DMO.
Ryoichi Ishibashi, Yoko Takatsuna, Masaya Koshizaka, Tomoaki Tatsumi, Sho Takahashi, Kengo Nagashima, Ko Ishikawa, Tomomi Kaiho, Noriko Asaumi, Takayuki Baba, Shuichi Yamamoto, Koutaro Yokote, The COMET Trial investigators   +12 more
wiley   +1 more source

Latanoprost and Cystoid Macular Edema

, 2003
Anil Negi
openalex   +1 more source

A Phase II Randomized Clinical Trial of Intravitreal Bevacizumab for Diabetic Macular Edema [PDF]

, 2007
Ingrid U. Scott, Allison R. Edwards, Roy W. Beck, Neil M. Bressler, Clement K. Chan, Michael J. Elman, Scott M. Friedman, Craig M. Greven, Raj K. Maturi, Dante J. Pieramici, Michel Shami, Lawrence J. Singerman, Cynthia R. Stockdale   +12 more
openalex   +1 more source

Intravitreal bevacizumab (Avastin) in the treatment of macular edema secondary to retinal vein occlusion [PDF]

, 2008
Juan Carlos Mesa-Gutiérrez
openalex   +3 more sources

Allergic Contact Dermatitis to Povidone‐Iodine and Systemic Contact Dermatitis to Chloramphenicol, Used During Intravitreal Injection of Bevacizumab, an Anti‐Vascular Endothelial Growth Factor

Contact Dermatitis, EarlyView.
Tommaso Galeotti, Luca Stingeni, Leonardo Bianchi, Marta Tramontana, Katharina Hansel   +4 more
wiley   +1 more source

The quality, accuracy and appropriateness of UK optometric age‐related macular degeneration referrals

Ophthalmic and Physiological Optics, Volume 45, Issue 3, Page 799-809, May 2025.
Abstract Purpose Little is known about the quality of optometrists' referrals to secondary care for neovascular age‐related macular degeneration (nAMD), despite the need for timely intervention. We analysed the content and accuracy of optometrists' referrals for nAMD.
Corinne Fulcher, Christopher Davey, Jonathan Denniss   +2 more
wiley   +1 more source

Edema macular quístico inducido por Travoprost

, 2004
Almudena del Hierro Zarzuelo, J.M. Martínez-de-la-Casa, J. García–Sánchez, Ana Gómez, Carmen Méndez-Hernández, Julián García Sánchez   +5 more
openalex   +1 more source